A single topical agent is clinically equivalent to the combination of topical and oral antibiotic treatment for otitis externa

American Journal of Otolaryngology - Head and Neck Medicine and Surgery

Volumn 29, Issue 4, 2008, Pages 255-261

  Roland, Peter S ^a   Belcher, Barbara P ^b   Bettis, Robert ^c   Makabale, Reynaldo L ^d   Conroy, Peter J ^e   Wall, G Michael ^e   Dupre, Sheryl ^e   Potts, Susan ^e   Hogg, Gail ^e   Weber, Kaye ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Protocare Trials   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d General Pediatrics   (United States)

^e ALCON RESEARCH LTD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CIPRO HC; CIPROFLOXACIN; CIPROFLOXACIN PLUS HYDROCORTISONE; CORTISPORIN; HYDROCORTISONE; HYDROCORTISONE PLUS NEOMYCIN PLUS POLYMYXIN B; NEOMYCIN; POLYMYXIN B;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BREAST CANCER; CHILD; CLINICAL ASSESSMENT; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG WITHDRAWAL; ERADICATION THERAPY; EXTERNAL OTITIS; FEMALE; FLATULENCE; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; OTALGIA; OTITIS MEDIA; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CHILD; CHILD, PRESCHOOL; CIPROFLOXACIN; FEMALE; HUMANS; HYDROCORTISONE; INFANT; MALE; MIDDLE AGED; NEOMYCIN; OTITIS EXTERNA; POLYMYXINS; THERAPEUTIC EQUIVALENCY; TREATMENT OUTCOME;

EID: 45849113981     PISSN: 01960709     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjoto.2007.09.002     Document Type: Article

References (28)

1. Halpern M.T., Palmer C.S., and Seidlin M. Treatment patterns for otitis externa. J Am Board Fam Pract 12 (1999) 1-7
2. Goldblatt E.L., Dohar J., Nozza R.J., et al. Topical ofloxacin versus systemic amoxicillin/clavulanate in purulent otorrhea in children with tympanostomy tubes. Int J Pediatr Otorhinolaryngol 46 1-2 (1998) 91-101
3. Ghosh S., Panarese A., Parker A.J., et al. Quinolone ear drops for chronic otitis media. They are safer and more effective than aminoglycosides. BMJ 321 7254 (2000) 126-127
4. Hannley M.T., Denneny III J.C., and Holzer S.S. Use of ototopical antibiotics in treating 3 common ear diseases. Otolaryngol Head Neck Surg 122 6 (2000) 934-940
5. Supiyaphun P., Kerekhanjanarong V., Koranasophonepun J., et al. Comparison of ofloxacin otic solution with oral amoxicillin plus chloramphenicol ear drop in treatment of chronic suppurative otitis media with acute exacerbation. J Med Assoc Thai 83 1 (2000) 61-68
6. Gydé M.C., Norris D., and Kavalec E.C. The weeping ear: clinical re-evaluation of treatment. J Int Med Res 10 (1982) 333-340
7. Wadsten C.-J., Bertilsson C.A., Sieradzki H., et al. A randomized clinical trial of two topical preparations (franmycitin/gramicidin and oxytetracycline/hydrocortisone with polymycin B) in the treatment of external otitis. Arch Otorhinolaryngol 242 (1985) 135-139
8. Browning G.G., Gatehouse S., and Calder I.T. Medical management of active chronic otitis media: a controlled study. J Laryngol Otol 102 6 (1988) 491-495
9. Crowther J.A., and Simpson D. Medical treatment of chronic otitis media: steroid or antibiotic with steroid ear drops?. Clin Otolaryngol 16 (1991) 142-144
10. Tong M.C.F., Woo J.K.S., and van Hasselt C.A. A double-blind comparative study of ofloxacin otic drops versus neomycin-polymyxin B-hydrocortisone otic drops in the medical treatment of chronic suppurative otitis media. J Laryngol Otol 110 (1996) 309-314
11. Welling D.B., Forrest L.A., and Goll III F. Safety of ototopical antibiotics. Laryngoscope 105 (1995) 472-474
12. Hester T.O., Jones R.O., Archer S.M., et al. Prophylactic antibiotic drops after tympanostomy tube placement. Arch Otolaryngol Head Neck Surg 121 (1995) 445-448
13. Pistorius B., Westberry K., Drehobl M., et al., Otitis Externa Study Group. Prospective, randomized, comparative trial of ciprofloxacin otic drops, with or without hydrocortisone, vs. polymyxin B-neomycin-hydrocortisone otic suspension in the treatment of acute diffuse otitis externa. Infect Dis Clin Pract 8 8 (1999) 387-395
14. Smith R.B., and Moodie J. Comparative efficacy and tolerability of two antibacterial/anti-inflammatory formulations ('Otomize' spray and 'Otosporin' drops) in the treatment of otitis externa in general practice. Curr Med Res Opin 11 (1990) 661-667
15. Jones R.N., Milazzo J., and Seidlin M. Ofloxacin otic solution for treatment of otitis externa in children and adults. Arch Otolaryngol Head Neck Surg 123 (1997) 1193-1200
16. McCoy S.I., Zell E.R., and Besser R.E. Antimicrobial prescribing for otitis externa in children. Pediatr Infect Dis J 23 2 (2004) 181-183
17. Rowlands S., Devalia H., Smith C., et al. Otitis externa in UK general practice: a survey using the UK General Practice Research Database. Br J Gen Pract 51 468 (2001) 533-538
18. Rosenfeld R.M., Brown L., Cannon C.R., et al. American Academy of Otolaryngology-Head Neck Surgery Foundation. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg 134 4 Suppl (2006) S4-S23
19. Altuntas A., Aslan A., Eren N., et al. Susceptibility of microorganisms isolated from chronic suppurative otitis media to ciprofloxacin. Eur Arch Otorhinolarygol 253 (1996) 364-366
20. Wiedemann B., and Grimm H. Susceptibility to antibiotics: Species incidence and trends. In: Lorian V. (Ed). Antibiotics in Laboratory Medicine (1996), Williams and Wilkins, Baltimore 900-1168
21. Brun J. Patient compliance with once-daily and twice-daily oral formulations of 5-isosorbide mononitrate: a comparative study. J Int Med Res 22 (1994) 266-272
22. Kruse W., Eggert-Kruse W., Rampmaier J., et al. Dosage frequency and drug-compliance behaviour-a comparative study on compliance with a medication to be taken twice or four times daily. Eur J Clin Pharmacol 41 6 (1991) 589-592
23. Roland P.S. Clinical ototoxicity of topical antibiotic drops. Otolaryngol Head Neck Surg 110 (1994) 598-602
24. Rackover Y., Keywan K., and Rosen G. Safety of topical ear drops containing ototoxic antibiotics. J Otolaryngol 26 3 (1997) 194-196
25. Podoshin L., Fradis M., and Ben-David J. Ototoxicity of ear drops in patients suffering from chronic otitis media. J Laryngol Otol 103 (1989) 46-50
26. Ruben R.J. Efficacy of ofloxacin and other otic preparations for otitis externa. Pediatr Infect Dis J 20 1 (2001) 109-110
27. Chyský V., Kapila K., Hullmann R., et al. Safety of ciprofloxacin in children: worldwide clinical experience based on compassionate use. emphasis on joint evaluation. Infection 19 4 (1991) 289-296
28. Heaton J.D., and Hackett R.B. Systemic and ocular safety of ciprofloxacin ophthalmic solution (Ciloxan) in immature animals. J Toxicol Cutan Ocul Toxicol 12 4 (1993) 273-283